Stock Events

Stock Events

Search...

Regulus Therapeutics (RGLS) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.41

-0.35

-0.29

-0.22

Details

Expected EPS

-0.2225

Actual EPS

-0.29

Surprise EPS

-0.07

Surprise Percent

+30.34%

Description

Regulus Therapeutics (RGLS) has reported earnings of -0.29 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.